We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Roche Gains FDA Clearance for Respiratory Test Panel

Rows of laboratory sample tubes with colorful caps arranged in a rack for medical testing and diagnostic analysis.
Credit: Testalize.me / Unsplash.
Read time: Less than a minute

Roche announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the cobas® eplex respiratory pathogen panel 3 (RP3). Designed for the automated cobas® eplex system, this flexible syndromic test offers up to five customizable panel configurations, enabling labs and clinicians to rapidly and accurately identify the cause of respiratory infections to help ensure timely and effective patient care.


During peak respiratory seasons, health systems face immense pressure to accurately differentiate viral and bacterial infections that often have overlapping symptoms. When clinicians have accurate and rapid respiratory results, they can reduce the number of tests and radiographs ordered, decrease unnecessary antibiotic use and decrease the length of time to discharge.1

"Timely and accurate respiratory testing in critical situations can guide life-saving interventions. The cobas® eplex RP3 panel gives laboratories the range of testing choices they need with quick turnaround times that can make a difference in patient care." — Dan Malarek, President and CEO of Roche Diagnostics North America

 Diagnostic uncertainty creates challenges, particularly for high-risk populations – including the elderly, young children and the immunocompromised – who are at increased risk for severe complications.2 The cobas® eplex RP3 panel addresses these challenges by providing rapid, actionable insights that facilitate efficient patient management and antibiotic stewardship.

This article has been republished from external sources. Note: Material may have been edited for clarity, length, or style. For more information, please contact the cited source.                
Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.